The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
— Read on www.nytimes.com/2018/10/26/health/private-equity-dermatology.html
Why Private Equity Is Furious Over a Paper in a Dermatology Journal – The New York Times
